United States Healthcare Equipment & Supplies

Bio Rad Laboratories Inc (BIO)

Track

Over the last 90 days, Bio Rad Laboratories Inc. has seen net insider selling totaling $135,597.00, with three transactions recorded. All transactions were sales, indicating a net outflow of capital from insiders. The stock has experienced a 13.8% price increase over the past 90 days.

Top insider sells (90, 60, 30d)

Top executive sells (90, 60, 30d)

Featured in screeners

Top insider sells

Top executive sells

Stock chart

Ticker: BIO Exchange: NYS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Alles Institute for Medical Research Corp

Director; 10% Stockholder

1 sale — total 100,000 USD

Proposed sale 28 May 2026

Value US$884,284.09 | Price 50.20 | Shares 16,024

ENGELHARDT EVA ANETTE

EVP, President, CDG

1 sale — total 100,000 USD

Sale 11 May 2026

Value US$4,430,840.44 | Price 49.78 | Shares 74,213

EVA ENGELHARDT

Officer

1 sale — total 135,597 USD

Proposed sale 11 May 2026

Value US$135,597.00 | Price 246.54 | Shares 550

MICHAEL W CROWLEY

Officer

1 sale — total 247,979 USD

Proposed sale 2 Dec 2025

Value US$247,978.56 | Price 319.56 | Shares 776

Alles Institute for Medical Research Corp

Director; 10% Stockholder

1 sale — total 228,793 USD

Proposed sale 18 Nov 2025

Value US$228,793.04 | Price 301.04 | Shares 760

BARRY JAMES

EVP, President, LSG

1 sale — total 214,289 USD

Sale 6 Nov 2025

Value US$214,288.51 | Price 306.18 | Shares 700

JAMES BARRY

Officer

1 sale — total 214,633 USD

Proposed sale 6 Nov 2025

Value US$214,633.08 | Price 306.18 | Shares 701

MICHAEL W CROWLEY

Officer

1 sale — total 410,572 USD

Proposed sale 5 Aug 2025

Value US$410,571.64 | Price 275.92 | Shares 1,488

Crowley Michael

EVP, GBL Commercial Operations

1 sale — total 741,184 USD

Sale 14 Mar 2025

Value US$741,184.20 | Price 247.06 | Shares 3,000

Crowley Michael

Officer

1 sale — total 780,000 USD

Proposed sale 13 Mar 2025

Value US$780,000.00 | Price 260.00 | Shares 3,000

Alles Institute for Medical Research Corp

Director; 10% Stockholder

1 sale — total 101,540 USD

Proposed sale 11 Mar 2025

Value US$101,539.65 | Price 247.66 | Shares 410

Last Andrew J.

Officer

1 sale — total 1,120,934 USD

Proposed sale 6 Nov 2024

Value US$1,120,934.04 | Price 373.64 | Shares 3,000

Last Andrew J.

Officer

1 sale — total 514,505 USD

Proposed sale 12 Sep 2024

Value US$514,504.96 | Price 321.57 | Shares 1,600

Last Andrew J.

EVP, Chief Operating Officer

2 sales — total 1,979,630 USD

Sale 6 Sep 2024

Value US$989,815.20 | Price 329.94 | Shares 3,000

Proposed sale 6 Sep 2024

Value US$989,815.20 | Price 329.94 | Shares 3,000

BARRY JAMES

Officer

2 sales — total 411,796 USD

Proposed sale 4 Sep 2024

Value US$205,898.15 | Price 330.49 | Shares 623

Sale 4 Sep 2024

Value US$205,898.14 | Price 330.49 | Shares 623

Alles Institute for Medical Research Corp

Director; 10% Stockholder

1 sale — total 308,225 USD

Proposed sale 27 Aug 2024

Value US$308,224.62 | Price 311.34 | Shares 990

Crowley Michael

EVP, GBL Commercial Operations

2 sales — total 208,047 USD

Sale 13 Jun 2024

Value US$104,023.46 | Price 281.91 | Shares 369

Proposed sale 13 Jun 2024

Value US$104,023.46 | Price 281.91 | Shares 369

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-05-28	2026-05-28	PrS Proposed sale	Alles Institute for Medical Research Corp Director; 10% Stockholder Non-Executive Director Large shareholder	16,024 50.20 US$884,284	16,024	50.20	US$884,284
2026-05-13	2026-05-11	S Sale	ENGELHARDT EVA ANETTE EVP, President, CDG Officer	74,213 +19.2% 49.78 US$4,430,840	74,213 +19.2%	49.78	US$4,430,840
2026-05-11	2026-05-11	PrS Proposed sale	EVA ENGELHARDT Officer Officer	34,306 313.70 US$3,993,048	34,306	313.70	US$3,993,048
2025-12-02	2025-12-02	PrS Proposed sale	3.0 MICHAEL W CROWLEY Officer Officer	776 319.56 US$247,979	776	319.56	US$247,979
2025-11-18	2025-11-18	PrS Proposed sale	Alles Institute for Medical Research Corp Director; 10% Stockholder Non-Executive Director Large shareholder	760 301.04 US$228,793	760	301.04	US$228,793
2025-11-10	2025-11-06	S Sale	2.4 BARRY JAMES EVP, President, LSG Officer	700 -57.9% 306.18 US$214,289	700 -57.9%	306.18	US$214,289
2025-11-06	2025-11-06	PrS Proposed sale	2.4 JAMES BARRY Officer Officer	701 306.18 US$214,633	701	306.18	US$214,633
2025-08-05	2025-08-05	PrS Proposed sale	3.0 MICHAEL W CROWLEY Officer Officer	1,488 275.92 US$410,572	1,488	275.92	US$410,572
2025-03-18	2025-03-14	S Sale	3.0 Crowley Michael EVP, GBL Commercial Operations Officer	3,000 -26.9% 247.06 US$741,184	3,000 -26.9%	247.06	US$741,184
2025-03-13	2025-03-13	PrS Proposed sale	3.0 Crowley Michael Officer Officer	3,000 260.00 US$780,000	3,000	260.00	US$780,000
2025-03-11	2025-03-11	PrS Proposed sale	Alles Institute for Medical Research Corp Director; 10% Stockholder Non-Executive Director Large shareholder	410 247.66 US$101,540	410	247.66	US$101,540
2024-11-06	2024-11-06	PrS Proposed sale	2.1 Last Andrew J. Officer Officer	3,000 373.64 US$1,120,934	3,000	373.64	US$1,120,934
2024-09-12	2024-09-12	PrS Proposed sale	2.1 Last Andrew J. Officer Officer	1,600 321.57 US$514,505	1,600	321.57	US$514,505
2024-09-10	2024-09-06	S Sale	2.1 Last Andrew J. EVP, Chief Operating Officer Officer	3,000 -28.4% 329.94 US$989,815	3,000 -28.4%	329.94	US$989,815
2024-09-06	2024-09-06	PrS Proposed sale	2.1 Last Andrew J. Officer Officer	3,000 329.94 US$989,815	3,000	329.94	US$989,815
2024-09-04	2024-09-04	PrS Proposed sale	2.4 BARRY JAMES Officer Officer	623 330.49 US$205,898	623	330.49	US$205,898
2024-09-04	2024-09-04	S Sale	2.4 BARRY JAMES EVP, President, LSG Officer	623 -81.0% 330.49 US$205,898	623 -81.0%	330.49	US$205,898
2024-08-27	2024-08-27	PrS Proposed sale	Alles Institute for Medical Research Corp Director; 10% Stockholder Non-Executive Director Large shareholder	990 311.34 US$308,225	990	311.34	US$308,225
2024-06-14	2024-06-13	S Sale	3.0 Crowley Michael EVP, GBL Commercial Operations Officer	369 -5.3% 281.91 US$104,023	369 -5.3%	281.91	US$104,023
2024-06-13	2024-06-13	PrS Proposed sale	3.0 Crowley Michael Officer Officer	369 281.91 US$104,023	369	281.91	US$104,023